RABINOWITZ DANIEL sold $136K of NTRA
RABINOWITZ DANIEL (SEC. AND CHIEF LEGAL OFFICER) sold 341 shares of Natera, Inc. (NTRA) at an average of $400.05 ($388.20–$400.29, $0.14M total) across 2 trades on 2026-11-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed insider sale is a routine filing with modest informational content; it is unlikely to move the stock significantly.
Market read
The filing provides a small data point for traders monitoring insider activity but offers limited trading impetus.
What to watch
The insider holds a large remaining stake (167,880 shares) indicating continued commitment.
Background
Natera, Inc. (NTRA) is a US‑listed company specializing in non‑invasive prenatal testing and oncology diagnostics.
Ticker impact
SEC Form 4 shows chief legal officer sold $136K of shares via a 10b5‑1 plan.
likely modest pressure as the market prices the insider sell.
The sale size is small relative to market cap and was pre‑arranged, limiting informational value.
Market effects
Minimal impact on the broader genetic testing sector.
No discernible regional effect.
Limited relevance beyond Natera shareholders.
Counterpoint
The sale could be purely liquidity‑driven and not reflect confidence issues.
Key entities
- OfficerRabinowitz Daniel
Chief Legal Officer and insider who sold shares.



